This inventor holds 1 USPTO granted patent. Top assignee: Solco Basel Ag. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovations of Peter Zimmerman
Introduction
Peter Zimmerman is a notable inventor based in Villingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on lactosyl compounds. His research focuses on developing compounds that exert a pronounced specific cytoprotective effect, which can be utilized in treating acute and chronic inflammations as well as organ ischemias.
Latest Patents
Zimmerman holds a patent for pharmaceutical products and lactosyl compounds. The compounds he developed are characterized by a specific formula that includes aliphatic radicals and acyl radicals derived from fatty acids. This invention is particularly relevant for its potential applications in medical treatments, showcasing Zimmerman's commitment to advancing healthcare solutions.
Career Highlights
Throughout his career, Peter Zimmerman has been associated with Solco Basel AG, where he has contributed to various research initiatives. His work has led to the development of innovative pharmaceutical products that address critical health issues. Zimmerman's expertise in the field has positioned him as a valuable asset to his company and the broader scientific community.
Collaborations
Zimmerman has collaborated with notable colleagues, including Richard R. Schmidt and Thomas Baer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their collective work.
Conclusion
Peter Zimmerman's contributions to pharmaceutical innovations highlight his dedication to improving health outcomes through scientific research. His patented compounds represent a significant advancement in the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile